{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:24:54Z","timestamp":1794489894911,"version":"4.9.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>\n                    Atypical intraductal proliferation (AIP) of the prostate is characterized by morphologic features exceeding that of high-grade prostatic intraepithelial neoplasia but not meeting strict diagnostic criteria for intraductal carcinoma. We examined the clinical significance of AIP in biopsy specimens. Patients with AIP diagnosed on biopsy were identified from surgical pathology archives. Initial biopsies, any repeat biopsies, and any radical prostatectomy (RP) slides were rereviewed. We also identified a control group of 50 consecutive patients with available prostate biopsies showing invasive prostatic adenocarcinoma but no AIP and having paired RP \ufefffor comparison. Medical records were searched for nonsurgical treatment and clinical outcome status. Patients with initial biopsies showing invasive adenocarcinoma with either grade group (GG) \u22653 and\/or unfavorable histology (as recently defined) were excluded from both the study and control groups. Correlation with subsequent adverse pathology at rebiopsy or RP, as defined by separate criteria: unfavorable histology, large cribriform\/intraductal carcinoma, GG \u22653, pN1, and\/or pM1, was assessed for both groups. Phosphate and tensin (PTEN) homolog and ETS-related gene (ERG) immunohistochemistry were performed on biopsies with available paired RP, using standard protocols. One hundred forty-two patients with AIP met inclusion criteria. At initial biopsy, 16 patients (11.3%) had AIP without concomitant invasive carcinoma, whereas 126 (88.7%) also had invasive adenocarcinoma. Of the 126 invasive tumors with AIP meeting study criteria, 19 (15.1%) were GG 1 and 107 (84.9%) GG 2. One hundred thirty-nine of 142 patients with AIP (97.9%) had available clinical follow-up (mean: 36.9 mo). Fifty-two (36.3%) patients with AIP underwent RP, 36 (25.4%) had brachytherapy, 28 (19.7%) had radiotherapy, 17 (12%) remained on active surveillance, 2 (1.4%) had cryoablation, 2 (1.4%) received androgen deprivation therapy, and 1 (0.7%) had high-intensity focused ultrasound. Forty-seven of 52 patients undergoing prostatectomy (90.3%) had glass slides available for review: 30 (63.8%) were GG2, 13 (27.7%) GG3, 1 (2.1%) GG4, and 3 (6.4%) GG5. Seventeen (36.2%) patients were staged as pT2, 25 (53.2%) pT3a, and 5 (10.6%) pT3b. Forty-two of 47 (89.4%) patients had associated unfavorable histology on prostatectomy, including 41 (87.2%) with large cribriform\/intraductal carcinoma, 17 (36.2%) GG\u22653, and 5 (10.6%) with metastatic disease. In the 36 AIP lesions examined for PTEN and ERG immunoreactivity, 14 (38.9%) had concomitant PTEN loss and ERG over-expression, 6 (16.7%) showed PTEN loss only, and 6 (16.7%) had ERG overexpression only. AIP morphology was more predictive of risk for unfavorable histology at RP than PTEN\/ERG immunophenotype. Seventeen patients not undergoing RP had rebiopsy, of which 5 (29.4%) had at least one adverse feature identified on repeat biopsy. Nineteen of 50 patients (38%) in the non-AIP control group had adverse pathology at RP (by any definition), compared with 89.4% in the AIP study group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.0001). In conclusion, AIP in prostate needle core biopsy is strongly associated with unsampled adverse pathology, defined by unfavorable histology and other traditional definitions of aggressive disease. For optimal patient risk stratification and active surveillance management, AIP should gain better recognition as a standard reporting element given its association with an increased likelihood of unsampled high-risk disease.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002376","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T03:04:01Z","timestamp":1740452641000},"page":"515-522","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Atypical Intraductal Proliferation in Prostate Needle Core Biopsy"],"prefix":"10.1097","volume":"49","author":[{"given":"Roshan","family":"Bhattarai","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Diagnostics Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse K.","family":"McKenney","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Diagnostics Institute"},{"name":"Department of Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Alaghehbandan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Diagnostics Institute"},{"name":"Department of Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni M.","family":"Cox","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Myles","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Diagnostics Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Przybycin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Diagnostics Institute"},{"name":"Department of Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Williamson","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Diagnostics Institute"},{"name":"Department of Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Weight","sequence":"additional","affiliation":[{"name":"Department of Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyad","family":"Schwen","sequence":"additional","affiliation":[{"name":"Department of Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane K.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Diagnostics Institute"},{"name":"Department of Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"R1-20250416","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.juro.2010.06.017","article-title":"Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings","volume":"184","author":"Robinson","year":"2010","journal-title":"J Urol"},{"key":"R2-20250416","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-5347(05)00337-X","article-title":"Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care","volume":"175","author":"Epstein","year":"2006","journal-title":"J Urol"},{"key":"R3-20250416","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/01.pas.0000213324.97294.54","article-title":"Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma","volume":"30","author":"Netto","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R5-20250416","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/his.13878","article-title":"Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes","volume":"75","author":"Shah","year":"2019","journal-title":"Histopathology"},{"key":"R6-20250416","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/modpathol.3800702","article-title":"Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance","volume":"19","author":"Guo","year":"2006","journal-title":"Mod Pathol"},{"key":"R7-20250416","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/his.13273","article-title":"Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma","volume":"71","author":"Shah","year":"2017","journal-title":"Histopathology"},{"key":"R9-20250416","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","article-title":"The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer","volume":"145","author":"Epstein","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"R11-20250416","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/PAS.0000000000000794","article-title":"Atypical intraductal cribriform proliferations of the prostate exhibit similar molecular and clinicopathologic characteristics as intraductal carcinoma of the prostate","volume":"41","author":"Hickman","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R12-20250416","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/PAS.0000000000000348","article-title":"Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy","volume":"39","author":"Morais","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R13-20250416","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/modpathol.2012.201","article-title":"Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia","volume":"26","author":"Lotan","year":"2013","journal-title":"Mod Pathol"},{"key":"R14-20250416","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/PAP.0b013e31825c6c0e","article-title":"Atypical cribriform lesions of the prostate: clinical significance, differential diagnosis and current concept of intraductal carcinoma of the prostate","volume":"19","author":"Shah","year":"2012","journal-title":"Adv Anat Pathol"},{"key":"R15-20250416","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/his.15231","article-title":"Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage","volume":"85","author":"Nguyen","year":"2024","journal-title":"Histopathology"},{"key":"R16-20250416","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ejca.2014.03.009","article-title":"Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort","volume":"50","author":"Trudel","year":"2014","journal-title":"Eur J Cancer"},{"key":"R18-20250416","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41379-018-0157-9","article-title":"Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis","volume":"32","author":"Hollemans","year":"2019","journal-title":"Mod Pathol"},{"key":"R19-20250416","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/modpathol.2014.116","article-title":"Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer","volume":"28","author":"Kweldam","year":"2015","journal-title":"Mod Pathol"},{"key":"R20-20250416","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/his.15102","article-title":"Large cribriform glands (>0.25 mm diameter) as a predictor of adverse pathology in men with grade group 2 prostate cancer","volume":"84","author":"Greenland","year":"2024","journal-title":"Histopathology"},{"key":"R21-20250416","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/modpathol.2017.29","article-title":"Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer","volume":"30","author":"Kweldam","year":"2017","journal-title":"Mod Pathol"},{"key":"R22-20250416","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/his.14658","article-title":"Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies","volume":"80","author":"Rijstenberg","year":"2022","journal-title":"Histopathology"},{"key":"R23-20250416","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ejca.2020.09.016","article-title":"Cribriform architecture prostatic adenocarcinoma in needle biopsies is a strong independent predictor for lymph node metastases in radical prostatectomy","volume":"148","author":"Downes","year":"2021","journal-title":"Eur J Cancer"},{"key":"R24-20250416","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejca.2016.07.012","article-title":"Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma","volume":"66","author":"Kweldam","year":"2016","journal-title":"Eur J Cancer"},{"key":"R25-20250416","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/his.13747","article-title":"Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set","volume":"74","author":"Masoomian","year":"2019","journal-title":"Histopathology"},{"key":"R26-20250416","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/his.13893","article-title":"Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens","volume":"75","author":"Hollemans","year":"2019","journal-title":"Histopathology"},{"key":"R27-20250416","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/JU.0000000000000526","article-title":"Diagnostic accuracy of prostate biopsy for detecting cribriform gleason pattern 4 carcinoma and intraductal carcinoma in paired radical prostatectomy specimens: implications for active surveillance","volume":"203","author":"Ericson","year":"2020","journal-title":"J Urol"},{"key":"R28-20250416","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.euf.2023.08.010","article-title":"Limitations of prostate biopsy in detection of cribriform and intraductal prostate cancer","volume":"10","author":"Bernardino","year":"2024","journal-title":"Eur Urol Focus"},{"key":"R29-20250416","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0046-8177(93)90041-E","article-title":"Architectural patterns of high-grade prostatic intraepithelial neoplasia","volume":"24","author":"Bostwick","year":"1993","journal-title":"Hum Pathol"},{"key":"R30-20250416","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00428-019-02544-6","article-title":"Intraductal carcinoma of the prostate: a critical re-appraisal","volume":"474","author":"Varma","year":"2019","journal-title":"Virchows Arch"},{"key":"R31-20250416","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/PAS.0000000000001819","article-title":"Intraductal adenocarcinoma of the prostate with cribriform or papillary ductal morphology: rare biopsy cases lacking associated invasive high-grade carcinoma","volume":"46","author":"Russell","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R32-20250416","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.humpath.2016.04.017","article-title":"ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma","volume":"55","author":"Morais","year":"2016","journal-title":"Hum Pathol"},{"key":"R33-20250416","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.3390\/cimb45040181","article-title":"Correlations of PTEN and ERG immunoexpression in prostate carcinoma and lesions related to its natural history: clinical perspectives","volume":"45","author":"Voulgari","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"R34-20250416","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/pros.23130","article-title":"Histopathological features of intra-ductal carcinoma of prostatic and high grade prostatic intraepithelialneoplasia and correlation with PTEN and P63","volume":"76","author":"Torabi-Nezhad","year":"2016","journal-title":"Prostate"},{"key":"R35-20250416","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cancergencyto.2006.04.003","article-title":"Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias","volume":"169","author":"Yoshimoto","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"R36-20250416","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.humpath.2015.01.008","article-title":"Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling","volume":"46","author":"Shah","year":"2015","journal-title":"Hum Pathol"},{"key":"R37-20250416","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/pin.13369","article-title":"PTEN loss in intraductal carcinoma of the prostate has low incidence in Japanese patients","volume":"73","author":"Ito","year":"2023","journal-title":"Pathol Int"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T10:00:43Z","timestamp":1744797643000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002376"}},"subtitle":["Validation as a Marker of Unsampled Adverse Pathology in a Clinicopathologic Series of 142 New Patients"],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002376","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]}}}